Posted by Michael Wonder on 10 Mar 2023
ICER to assess gene therapy for metachromatic leukodystrophy
9 March 2023 - Report will be subject of CTAF meeting in September 2023; draft scoping document open to public comment until 30 March 2023.
The ICER announced today that it will assess the comparative clinical effectiveness and value of atidarsagene autotemcel (Orchard Therapeutics) for metachromatic leukodystrophy.
